Inhibikase Therapeutics, Inc. - IKT

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 28
Latest filed: Sep 08, 2026
Form Count
8-K 10
SCHEDULE 13G/A 8
4 8
SCHEDULE 13G 2

Latest files

Filed Form Report period Accession SEC
Sep 08, 2026 8-K Sep 08, 2026 0001193125-26-385293 View
Aug 26, 2026 8-K Aug 21, 2026 0001193125-26-368296 View
Aug 14, 2026 SCHEDULE 13G/A 0001193125-26-352638 View
Aug 14, 2026 SCHEDULE 13G/A 0001104659-26-097282 View
Aug 13, 2026 SCHEDULE 13G/A 0001875620-26-000017 View
Aug 11, 2026 8-K Aug 11, 2026 0001193125-26-344623 View
Jul 31, 2026 4 Jul 29, 2026 0001231919-26-000815 View
Jul 31, 2026 SCHEDULE 13G/A 0001346824-26-000206 View
Jul 31, 2026 4 Jul 30, 2026 0001193125-26-328467 View
Jul 29, 2026 8-K Jul 29, 2026 0001193125-26-323651 View
Jul 28, 2026 SCHEDULE 13G 0002012383-26-002526 View
Jul 23, 2026 8-K Jul 23, 2026 0001193125-26-313400 View
Jul 17, 2026 SCHEDULE 13G 0001346824-26-000193 View
Jul 14, 2026 8-K Jul 14, 2026 0001193125-26-302580 View
Jun 30, 2026 4 Jun 26, 2026 0001193125-26-290470 View
Jun 30, 2026 4 Jun 26, 2026 0001193125-26-290472 View
Jun 30, 2026 4 Jun 26, 2026 0001193125-26-290474 View
Jun 30, 2026 4 Jun 26, 2026 0001193125-26-290475 View
Jun 30, 2026 4 Jun 26, 2026 0001193125-26-290476 View
Jun 30, 2026 4 Jun 26, 2026 0001193125-26-290477 View
Jun 29, 2026 8-K Jun 26, 2026 0001193125-26-286747 View
May 15, 2026 SCHEDULE 13G/A 0001104659-26-062874 View
May 15, 2026 SCHEDULE 13G/A 0001193125-26-226561 View
May 15, 2026 SCHEDULE 13G/A 0001493152-26-023791 View
May 15, 2026 SCHEDULE 13G/A 0001831942-26-000019 View
May 12, 2026 8-K May 12, 2026 0001193125-26-219610 View
Apr 07, 2026 8-K Apr 07, 2026 0001193125-26-144582 View
Mar 26, 2026 8-K Mar 26, 2026 0001193125-26-126322 View